PEGGI TORGUSON: Open Payments
NPI 1366419582 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 49 payments from 19 companies in 2025. Trend: 2023 $902 · 2024 $1,339 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $270 |
| ABBVIE INC. | 7 | $178 |
| Novo Nordisk Inc | 4 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $80 |
| Aimmune Therapeutics, Inc. | 3 | $68 |
| Astellas Pharma US Inc | 2 | $54 |
| Amgen Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $40 |
Products named: VRAYLAR, Ozempic, FARXIGA, CAPLYTA, ZENPEP, Veozah, REXULTI, AIRSUPRA.
Industry payments across CO — which companies pay providers there.
